EndoChoice's Fuse System Earns FDA 510(k) Clearance, Increases Adenoma Detection by 71%

Gastroenterology and Endoscopy

Share on Facebook
EndoChoice, Atlanta-based medical technology company focused on gastrointestinal diseases, has announced its Fuse System has recently received FDA 510(k) clearance.

Research has shown the Fuse System, three cameras attached to the end of an endoscope during colonoscopy procedures, to improve the detection rate of adenomas by 71 percent.

EndoChoice is displaying the Fuse System at Digestive Disease Week, held May 18 to 21 in Orlando, Fla.

More Articles on Gastroenterology:
Boston Scientific to Present Data at Digestive Disease Week
SAGES Appoints Dr. Gerald Fried President
PENTAX Launches Video Processor With PENTAX i-SCAN



© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New from Becker's ASC Review

EUS could replace ERCP for common bile duct stone detection

Read Now